Bergqvist Christina

Dermatologie

Hôpital Cochin
Paris, France

81 Activités

73 Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Neurofibromatoses Neurofibromatose de type 1 Neurofibrome Psoriasis Tumeurs cutanées Gliome Arthrite psoriasique Neurofibrome plexiforme Vitiligo

Collaborateurs

Wolkenstein Pierre

Hôpital Henri Mondor, Créteil, France

Tourte Maylis

Cabinet libéral, Bordeaux, France

Broly Marine

Centre Hospitalier Libourne, Libourne, France

Quiles Nathalie

Hôpital La Timone, Marseille, France

Industries

B3TSI

186 collaboration(s)

Dernière en 2023

IQVIA

66 collaboration(s)

Dernière en 2023

A+A

52 collaboration(s)

Dernière en 2023

Inter-View Partners France

14 collaboration(s)

Dernière en 2023

Dernières activités

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma: A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)

Essai Clinique (National Cancer Institute) 20 mars 2024

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma: A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)

Essai Clinique (National Cancer Institute) 14 mars 2024

Whole-body F-FDG-PET/MRI as a screening tool for the detection of malignant transformation in individuals with Neurofibromatosis type 1.

The Journal of investigative dermatology 16 février 2024

Rayons ultra-violets et développement des neurofibromes cutanés liés à la neurofibromatose de type 1 : point de vue des patients